The weight loss market has no signs of slowing down, with some reports suggesting there are nearly 160 obesity drugs currently in development by big pharma companies
Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P
They are now feeling more confidentI think a big one is to be able to participate in activities and sports that they felt like they couldnt before, which is, overall, a mood booster, said Herdes
However, there are important caveats: It is not FDA-approved for any medical treatment, so its use is considered off-label. BPC-157 is reported safe in recommended dosages
Here is how responsible GLP-1 sourcing works, and how to protect yourself from a fast-growing counterfeit market
Ravi, N., Choday, S., Shantha Kumar, V., Kc, A., Parisapogu, A., Ojinna, B
